Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Clinical Pathology
Published in: BMC Clinical Pathology 1/2017

Open Access 01-12-2017 | Case report

Inflammatory myofibroblastic tumor of the lacrimal gland: case report of an exceptional location

Authors: Adil Boudhas, Mohamed Allaoui, Fouad El Asri, Issam Rharrassi, Mohamed Reda El Ochi, Mohamed Tbouda, Hafsa Chahdi, Abderrahmane Al Bouzidi, Mohamed Oukabli

Published in: BMC Clinical Pathology | Issue 1/2017

Login to get access

Abstract

Background

Inflammatory myofibroblastic tumour (IMT) is a mesenchymal neoplasm of intermediate biological potential that may affect a wide range of anatomic sites but has a particular predilection for the lung and intra-abdominal soft tissues.

Case presentation

We report here an exceptional case of inflammatory myofibroblastic tumor arising in the lacrimal gland and presenting as an orbital mass in a 24-year-old male.

Conclusion

This report aims to discuss the importance of histopathological and immunohistochemical findings in arriving at the diagnosis, which helps dictate the management, treatment and prognosis of the patient.
Literature
1.
Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61:428–37.CrossRefPubMed
2.
Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859–72.CrossRefPubMed
3.
Fletcher CD, Mertens F, Bridge JA. WHO classification of Tumours of soft tissue and bone. International Agency for Research on Cancer. 4th ed. Geneva: WHO Press; 2013.
4.
Tawfik HA, Raslan AO. Infantile inflammatory myofibroblastic tumor of the orbit with apical bone involvement. Ophthal Plast Reconstr Surg. 2013;29:e44–6.CrossRefPubMed
5.
Lawrence B, Perez-Atayde A, Hibbard MK, Rubin BP, Dal Cin P, Pinkus JL, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumours. Am J Pathol. 2000;157:377–84.CrossRefPubMedPubMedCentral
6.
Patnana M, Sevrukov AB, Elsayes KM, et al. Inflammatory pseudotumor: the great mimicker. Am J Roentgenol. 2012;198:W217–27.CrossRef
7.
Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509–20.CrossRefPubMed
8.
Park SB, Lee JH, Weon YC. Imaging findings of head and neck inflammatory pseudotumor. AJR Am J Roentgenol. 2009;193:1180–6.CrossRefPubMed
9.
Dutta V, Manoj MG, Malik A, Kumar P. ALK negative inflammatory myofibroblastic tumor of the orbit: a masquerading entity. Indian J Ophthalmol. 2014;62(5):627–9.CrossRefPubMedPubMedCentral
10.
McDermott M. Myofibroblastic inflammatory tumour. Semin Diagn Pathol. 2016;33(6):358–66.CrossRef
11.
Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol. 1998;15(2):85–101.PubMed
12.
Pettinato G, Manivel JC, De Rosa N, Dehner LP. Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol. 1990;94(5):538–46.CrossRefPubMed
13.
Hussong JW, Brown M, Perkins SL, Dehner LP, Coffin CM. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Mod Pathol. 1999;12(3):279–86.PubMed
14.
Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol. 2002;15(9):931–8.CrossRefPubMed
15.
Cools J, Wlodarska I, Somers R, et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosom Cancer. 2002;34(4):354–62.CrossRefPubMed
16.
Sukov WR, Cheville JC, Carson AW, Shearer BM, Piatigorsky EJ, Grogg KL, Sebo TJ, Sinnwell JP, Ketterling RP. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol. 2007;20:592–603.CrossRefPubMed
17.
Souid AK, Ziemba MC, Dubansky AS, et al. Inflammatory myofibroblastic tumor in children. Cancer. 1993;172(6):2042–8.CrossRef
18.
Karnak I, Senocak ME, Ciftci AO, et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Pediatr Surg. 2001;36(6):908–12.CrossRefPubMed
19.
Donner LR, Trompler RA, White RR. Progression of inflammatory myofibroblastic tumor of soft tissue into sarcoma after several recurrences. Hum Pathol. 1996;27(10):1095–8.CrossRefPubMed
20.
21.
Polito E, Pichierri P, Loffredo A, Moramarco A, Occhini R. Inflammatory myofibroblastic tumor of the orbit. Ophthalmologica. 2007;221(5):353–5.CrossRefPubMed
22.
Sa HS, Ji JY, Suh YL, et al. Inflammatory myofibroblastic tumor of the orbit presenting as a subconjunctival mass. Ophthal Plast Reconstr Surg. 2005;21(3):211–5.CrossRefPubMed
Metadata
Title
Inflammatory myofibroblastic tumor of the lacrimal gland: case report of an exceptional location
Authors
Adil Boudhas
Mohamed Allaoui
Fouad El Asri
Issam Rharrassi
Mohamed Reda El Ochi
Mohamed Tbouda
Hafsa Chahdi
Abderrahmane Al Bouzidi
Mohamed Oukabli
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2017
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/s12907-017-0050-3

Other articles of this Issue 1/2017

BMC Clinical Pathology 1/2017 Go to the issue

Research article

Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X

Research article

Elevation of small, dense low density lipoprotein cholesterol—a possible antecedent of atherogenic lipoprotein phenotype in type 2 diabetes patients in Jos, North-Central Nigeria

Technical advance

Mapping mitochondrial heteroplasmy in a Leydig tumor by laser capture micro-dissection and cycling temperature capillary electrophoresis

Case report

De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review

Research article

High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival

Case report

Malignant Deciduoid Mesothelioma: case presentation of an exceptional variant and review of the literature

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits